# 💼 Dr Lal PathLabs Ltd – Financial Modeling & DCF Valuation

This project presents a comprehensive **3-statement financial model** and **Discounted Cash Flow (DCF)** based **Valuation** of **Dr Lal PathLabs Ltd**, a leading diagnostics and pathology services provider in India. The model forecasts financial performance from 2026 to 2030 and values the company under Base, Best, and Worst case scenarios.

---

## 📊 Project Highlights

- ✅ Built complete 3-statement model (Income Statement, Balance Sheet, Cash Flow)
- ✅ Modeled operational drivers such as test pricing, volume, lease costs, and working capital
- ✅ Performed full **DCF valuation** using unlevered free cash flows and terminal value
- ✅ Included **scenario analysis** (Base, Best, Worst) to assess valuation range
- ✅ Developed **sensitivity analysis** across **WACC (8.5%–10.5%)** and **terminal multiples (21x–29x)**
---

## 🧮 Key Valuation Outputs (Base Case)

| Metric                         | Value (₹ Cr.)        |
|-------------------------------|----------------------|
| Intrinsic Enterprise Value     | ₹ 24,570             |
| Intrinsic Equity Value         | ₹ 25,563             |
| Intrinsic Share Price          | ₹ 3,058              |
| Shares Outstanding (Cr.)       | 8.36                 |
| WACC                           | 9.5%                 |
| Terminal EBITDA Multiple       | 25x                  |
| Terminal Value (2030)          | ₹ 33,852             |

📈 Free cash flows were projected for 2026–2030, discounted using WACC, and combined with terminal value to calculate enterprise value.

---

## 📦 Files in This Repo

- `DCF_Model.xlsx` – Fully linked and dynamic Excel model
- `Dr_Lal_PathLabs_Ltd.pdf` – Output report and financial schedules
- `valuation_summary.png` – Snapshot of final valuation results

---

## 📐 Key Assumptions

- Revenue growth driven by test volume and pricing scenarios
- Cost inflation modeled for materials and lab test charges
- SG&A fixed as % of revenue
- Straight-line depreciation and amortization
- 25% corporate tax rate

---

## 🔄 Scenario Analysis – Intrinsic Share Price

| Scenario     | Share Price (₹) | **Enterprise Value (₹ Cr.)** |
|--------------|------------------|-------------------------------|
| **Base Case**  | ₹ 3,058           | ₹ 24,570                      |
| **Best Case**  | ₹ 3,305           | ₹ 26,637                      |
| **Worst Case** | ₹ 2,757           | ₹ 22,056                      |

---

## 📌 Tools Used

- Microsoft Excel (Advanced formulas, linked schedules)
- Discounted Cash Flow Valuation (DCF)
- Scenario & Sensitivity Analysis
- Financial Statement Analysis

---

## 🧠 About the Author

**👤 Titu Thomas**   
📫 [LinkedIn](https://linkedin.com/in/titu-thomas-cma) | ✉️ tituthomas17@gmail.com



